CSIRTS // UNIFIED SECURITY ADVISORY FEEDSYS ● ONLINE · POWERED BY INTELFUSIONS.COM

CVE-2026-14340: An incorrect authorization vulnerability was identified in GitHub Enterprise Server that allowed a user-to-server token scoped to a GitHub App installation to perform certain write

mediumCVSS 5CVE-2026-14340
An incorrect authorization vulnerability was identified in GitHub Enterprise Server that allowed a user-to-server token scoped to a GitHub App installation to perform certain write operations on public repositories outside the token's intended scope. This was possible because the authorization check only verified that the installation had read permissions on the target repository rather than verifying that the token's installation was explicitly granted access to that repository. An attacker who obtained a victim's user-to-server token could create issues, issue comments, commit comments, and private vulnerability reports on any public repository, appearing as the victim user with no indication of the app involvement. This vulnerability was fixed by adding a repository scope check for user-to-server tokens issued by global apps. This vulnerability affected all versions of GitHub Enterprise Server prior to 3.22 and was fixed in versions 3.21.2, 3.20.4, 3.19.8, 3.18.11, 3.17.17, 3.16.20. This vulnerability was reported via the GitHub Bug Bounty program.

Details

Source
NVD Recent CVEs (US · database · site)
Severity
medium — CVSS 5
Published
2026-07-01
Last updated
2026-07-06
Exploitation
Not in CISA KEV at last sync

Original advisory: https://nvd.nist.gov/vuln/detail/CVE-2026-14340

Exploitation outlook

EPSS (FIRST.org) estimates each CVE’s probability of exploitation in the next 30 days — here is the CSIRTS.com read on those numbers.

Referenced CVEs

CVECSIRTS overviewExternal
CVE-2026-14340coverage & exploitation statusNVD · CVE.org

Recent advisories for An incorrect authorization

A cluster of recent advisories against the same product widens the attack surface — attackers routinely chain freshly published CVEs on one product, so review these together.

More from NVD Recent CVEs